Table of Contents
1.1 List of Tables 17
1.2 List of Figures 28
2 Introduction 29
2.1 Women’s Health Overview 29
3 Products under Development 30
3.1 Women’s Health – Pipeline Products by Stage of Development 30
3.2 Women’s Health – Pipeline Products by Territory 31
3.3 Women’s Health – Pipeline Products by Regulatory Path 33
3.4 Women’s Health – Pipeline Products by Estimated Approval Date 34
3.5 Women’s Health – Ongoing Clinical Trials 35
4 Women’s Health – Pipeline Products under Development by Companies 36
4.1 Women’s Health Companies – Pipeline Products by Stage of Development 36
4.2 Women’s Health – Pipeline Products by Stage of Development 41
5 Women’s Health Companies and Product Overview 47
5.1 AblaCare Company Overview 47
5.1.1 AblaCare Pipeline Products & Ongoing Clinical Trials Overview 47
5.2 AdneXXA LLC Company Overview 50
5.2.1 AdneXXA LLC Pipeline Products & Ongoing Clinical Trials Overview 50
5.3 Advanced Prenatal Therapeutics, Inc. Company Overview 51
5.3.1 Advanced Prenatal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.4 Advanced Tactile Imaging Inc Company Overview 52
5.4.1 Advanced Tactile Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 52
5.5 AEGEA Medical Inc Company Overview 55
5.5.1 AEGEA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 55
5.6 Aethlon Medical Inc Company Overview 56
5.6.1 Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 56
5.7 Agile Therapeutics Inc Company Overview 57
5.7.1 Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 57
5.8 Allergan Plc Company Overview 60
5.8.1 Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview 60
5.9 AltaScience Limited Company Overview 62
5.9.1 AltaScience Limited Pipeline Products & Ongoing Clinical Trials Overview 62
5.10 Alydia Health Inc Company Overview 63
5.10.1 Alydia Health Inc Pipeline Products & Ongoing Clinical Trials Overview 63
5.11 Amniotix Technologies Ltd Company Overview 66
5.11.1 Amniotix Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 66
5.12 ANALYTICA PTY LTD Company Overview 67
5.12.1 ANALYTICA PTY LTD Pipeline Products & Ongoing Clinical Trials Overview 67
5.13 Aneeve Nanotechnologies LLC Company Overview 68
5.13.1 Aneeve Nanotechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview 68
5.14 Aspivix SA Company Overview 69
5.14.1 Aspivix SA Pipeline Products & Ongoing Clinical Trials Overview 69
5.15 Bayer AG Company Overview 70
5.15.1 Bayer AG Pipeline Products & Ongoing Clinical Trials Overview 70
5.16 Baystate Medical Center Company Overview 72
5.16.1 Baystate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 72
5.17 Becton Dickinson and Co Company Overview 73
5.17.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 73
5.18 BeFree! Company Overview 76
5.18.1 BeFree! Pipeline Products & Ongoing Clinical Trials Overview 76
5.19 BellaSeno GmbH Company Overview 77
5.19.1 BellaSeno GmbH Pipeline Products & Ongoing Clinical Trials Overview 77
5.20 Bewell Connect Corp Company Overview 78
5.20.1 Bewell Connect Corp Pipeline Products & Ongoing Clinical Trials Overview 78
6 Women’s Health- Recent Developments 289
6.1 Nov 19, 2019: Edan to highlight its new developments at MEDICA 2019 289
6.2 Nov 19, 2019: Clinical Innovations hires Rebecca Liu as VP, general manager for CI Medical Instruments in China 289
6.3 Nov 18, 2019: A new self-use innovative treatment for pelvic organ prolapse in women (POP) designed by ConTIPI Medical 290
6.4 Nov 18, 2019: Barbro Friden steps down as a member of the board of Vitrolife 291
6.5 Nov 14, 2019: Merck acquires Calporta Therapeutics for $576m 291
6.6 Nov 14, 2019: INVO Bioscience reports third quarter 2019 financial results 291
6.7 Nov 13, 2019: BellaSeno and Evonik to launch 3D-printed absorbable breast scaffold 293
6.8 Nov 13, 2019: Thermo Fisher Scientific opens Customer Solution Center in China to support pharmaceutical and biopharmaceutical laboratories 294
6.9 Nov 13, 2019: Atossa Genetics announces third quarter 2019 financial results and provides company update 294
6.10 Nov 13, 2019: Thermo Fisher Scientific announces membership of the Pistoia Alliance 296
7 Appendix 600
7.1 Methodology 600
7.2 About GlobalData 603
7.3 Contact Us 603
7.4 Disclaimer 603
Table 1: Women's Health - Pipeline Products by Stage of Development
Table 2: Women's Health - Pipeline Products by Territory
Table 3: Women's Health - Pipeline Products by Regulatory Path
Table 4: Women's Health - Pipeline Products by Estimated Approval Date
Table 5: Women's Health - Ongoing Clinical Trials
Table 6: Women's Health Companies - Pipeline Products by Stage of Development
Table 7: Women's Health - Pipeline Products by Stage of Development
Table 8: AblaCare Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AblaCare Kit - Product Status
Table 10: AblaCare Kit - Product Description
Table 11: AblaCare - Ongoing Clinical Trials Overview
Table 12: AblaCare Kit - ULTRA Study: A Feasibility, Prospective, Multicenter, Single-arm Trial of the AblaCare Device in Transvaginal Ablation of Ovarian Tissue Under Ultrasound Visualisation in Women with Polycystic Ovary Syndrome (PCOS)
Table 13: AdneXXA LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Reusable Contraception Device - Product Status
Table 15: Reusable Contraception Device - Product Description
Table 16: Advanced Prenatal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Targeted Apheresis Column for Preeclampsia (TAC-PE) - Product Status
Table 18: Targeted Apheresis Column for Preeclampsia (TAC-PE) - Product Description
Table 19: Advanced Tactile Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Antepartum Tactile Imager - Product Status
Table 21: Antepartum Tactile Imager - Product Description
Table 22: Cervix Monitor - Product Status
Table 23: Cervix Monitor - Product Description
Table 24: Restore-IT - Product Status
Table 25: Restore-IT - Product Description
Table 26: AEGEA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Next-Generation Adaptive Vapor Ablation System - Product Status
Table 28: Next-Generation Adaptive Vapor Ablation System - Product Description
Table 29: Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: HER2osome - Product Status
Table 31: HER2osome - Product Description
Table 32: Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: AG200-ER Patch - Product Status
Table 34: AG200-ER Patch - Product Description
Table 35: AG200-SP Patch - Product Status
Table 36: AG200-SP Patch - Product Description
Table 37: AG890 Patch - Product Status
Table 38: AG890 Patch - Product Description
Table 39: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Norethindrone Transdermal Delivery System - Product Status
Table 41: Norethindrone Transdermal Delivery System - Product Description
Table 42: Smooth 133 Plus TE - Product Status
Table 43: Smooth 133 Plus TE - Product Description
Table 44: AltaScience Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 45: AltaSeal - Product Status
Table 46: AltaSeal - Product Description
Table 47: Alydia Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 48: InPress Postpartum Hemorrhage Intrauterine Device - Product Status
Table 49: InPress Postpartum Hemorrhage Intrauterine Device - Product Description
Table 50: Alydia Health Inc - Ongoing Clinical Trials Overview
Table 51: InPress Postpartum Hemorrhage Intrauterine Device - Potential Approach to Treat Postpartum Hemorrhage Using InPress Postpartum Hemorrhage Intrauterine Device
Table 52: InPress Postpartum Hemorrhage Intrauterine Device - Prospective, Single Arm Pivotal Clinical Trial Designed to Assess the Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
Table 53: Amniotix Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Amniotic Fluid Spectral Monitoring Device - Product Status
Table 55: Amniotic Fluid Spectral Monitoring Device - Product Description
Table 56: ANALYTICA PTY LTD Pipeline Products & Ongoing Clinical Trials Overview
Table 57: PeriCoach System - Pelvic Organ Prolapse - Product Status
Table 58: PeriCoach System - Pelvic Organ Prolapse - Product Description
Table 59: Aneeve Nanotechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Hormone Level Monitor - Product Status
Table 61: Hormone Level Monitor - Product Description
Table 62: Aspivix SA Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Aspivix Device - Product Status
Table 64: Aspivix Device - Product Description
Table 65: Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
Table 66: LNG-IUS16 - Product Status
List of Figures
Figure 1: Women's Health - Pipeline Products by Stage of Development
Figure 2: Women's Health - Pipeline Products by Territory
Figure 3: Women's Health - Pipeline Products by Regulatory Path
Figure 4: Women's Health - Pipeline Products by Estimated Approval Date
Figure 5: Women's Health - Ongoing Clinical Trials
【免責事項】
https://www.marketreport.jp/reports-disclaimer